<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01013532</url>
  </required_header>
  <id_info>
    <org_study_id>PICASSO</org_study_id>
    <nct_id>NCT01013532</nct_id>
  </id_info>
  <brief_title>PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage</brief_title>
  <acronym>PICASSO</acronym>
  <official_title>A Multicenter, Double Blind, Factorial Design, Phase IV Trial to Compare the Efficacy and Safety of Cilostazol Long-term Treatment With Aspirin in Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage for the Prevention of Cerebral Hemorrhage and Cardiovascular Events and to Compare the Preventive Effect of Probucol in the Same Patient Group With Non-drug User Group for the Prevention of Cardiovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korea Otsuka Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through this study, the investigators are to prove that Cilostazol effectively prevent
      cardiovascular events in ischemic stroke patients with high risk of cerebral hemorrhage,
      along with no significant increase in the risk of occurrence of hemorrhagic side effects.

      The primary hypothesis of this study is; Cilostazol alone or with probucol will reduce the
      risk of cerebral hemorrhage without increase of cardiovascular events compared to aspirin in
      the ischemic stroke patients with symptomatic or asymptomatic old cerebral hemorrhage.

      This study will prove the superiority of cilostazol on the prevention of cerebral hemorrhagic
      events without increasing the cardiovascular events against aspirin and the superiority of
      probucol on the prevention of overall cardiovascular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been generally accepted that 'old age' and 'hypertension' may be risk factors not only
      for cerebral infarction but also for cerebral hemorrhage. Usually 40 to 60 percent of
      recurrent strokes after cerebral hemorrhage cases are cerebral infarction; and 5 to 10
      percent of recurrent stroke after cerebral infarction cases are cerebral hemorrhage.

      Consequently, for the reasons described above, hemorrhagic side effects including cerebral
      hemorrhage have been a great concern, in the usage of antiplatelet agent or anticoagulant for
      the secondary prevention in the patients with cerebral infarction.

      It is reported that the occurrence of cerebral hemorrhage tends to increase in cases of
      accompanying lacunar infarction which occurs more frequently in Asians than in Westerners, or
      periventricular ischemic change which increasingly occurs with ageing. Accordingly, the point
      is that the occurrence of cerebral hemorrhage should be primarily considered in the treatment
      of cerebral infarction, along with the phenomenon of an ageing population both in Asian
      countries including Korea.

      Nevertheless, so far there has been no clinical research regarding secondary prevention of
      stroke, particularly considering the risk of occurrence of hemorrhage in cerebral infarction
      cases. However, according to a recent study, when phosphodiesterase inhibitors including
      Cilostazol are used independently, or in combination with aspirin, secondary prevention can
      be improved without increasing the occurrence of hemorrhagic side effects.

      Considering this, if it is proved that the agent, Cilostazol, could decrease the risk of
      occurrence of stoke, along with no significant increase in the risk of occurrence of
      hemorrhagic side effects, by selecting a patent group with a high risk of cerebral
      hemorrhage, the agent (Cilostazol) may be recognized as an unique antiplatelet agent
      applicable to old-aged patient with cerebral infarction who have a certain risk of cerebral
      hemorrhage.

        -  High risk of cerebral hemorrhage is defined as presence of history of cerebral
           hemorrhage with appropriate neuroimage findings or presence of asymptomatic old cerebral
           hemorrhage findings(equal or more than 8mm) or multiple microbleeds on the GRE images.

        -  1600 ischemic stroke patients with high risk of cerebral hemorrhage will be recruited
           and they are randomized into four groups (cilostazol plus probucol, aspirin plus
           probucol, cilostazol and aspirin) by 2X2 factorial design.

        -  IMT and ABI will be measured every year during follow-up period and the results will be
           compared with the baseline data. The change of IMT and ABI will be analyzed with the
           occurrence of cardiovascular events.

        -  The study will finish at least 1 year after the recruit of 1600th patients. Until the
           finish, all patients will continuously take study medications and visit every 3months at
           the study site.

        -  Brain MRI including FLAIR and GRE will be done at the final visits.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to the first occurrence of cerebral hemorrhage</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to the first occurence of composite cardiovascular events</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to the first occurrence of stroke</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first occurrence of ischemic stroke</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first occurence of myocardial infarction</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first occurence of other designated vascular events</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence rate of major and non-major hemorrhagic event</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of asymptomatic hemorrhage in GRE (microhemorrhage or macrohemorrhage)</measure>
    <time_frame>at final visit, follow-up MRI will be checked at the final visit</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of new asymptomatic cerebral infarction lesion in FLAIR</measure>
    <time_frame>at final visit, follow-up MRI will be checked at the final visit</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change of ankle-brachial index</measure>
    <time_frame>at final visit;follow-up period is 1.0 to 5.5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The effect of the size of common carotid artery(CCA) including plaque on the occurrence of cardiovascular events</measure>
    <time_frame>at final visit;follow-up period is 1.0 to 5.5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Time to all deaths including vascular and non-vascular deaths</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence rate of dementia diagnosed after initiation of the trial</measure>
    <time_frame>time since randomization; follow-up period is 1.0 to 5.5 years</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Brain Ischemia</condition>
  <condition>Intracranial Hemorrhages</condition>
  <arm_group>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100mg cilostazol bid plus probucol plus placebo of aspirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>aspirin plus placebo cilostazol plus probucol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cilostazol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cilostazol plus placebo of aspirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>aspirin plus placebo of cilostazol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cilostazol</intervention_name>
    <description>Cilostazol 100mg bid</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
    <other_name>Pletaal produced by Korea Otsuka Pharmaceutical company</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Probucol</intervention_name>
    <description>Probucol 250mg bid</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <other_name>Probucol is produced by Otsuka Pharmaceutical</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>Aspirin 100mg qd</description>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo of cilostazol</intervention_name>
    <description>same shape and size of active cilostazol</description>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo of aspirin</intervention_name>
    <description>same size and shape of active aspirin 100mg</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ankle-brachial index (ABI)</intervention_name>
    <description>measurement of ABI every years during follow up</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intima-medial thickness (IMT)</intervention_name>
    <description>ultrasound measured IMT of both common carotid arteries</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
    <other_name>change of maximal IMT and mean IMT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>new asymptomatic brain hemorrhage</intervention_name>
    <description>asymptomatic macrobleedings or microbleedings on GRE images</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>new ischemic lesions on follow-up FLAIR images</intervention_name>
    <description>any new ischemic lesions</description>
    <arm_group_label>Cilostazol+ Probucol</arm_group_label>
    <arm_group_label>Aspirin + Probucol</arm_group_label>
    <arm_group_label>Cilostazol</arm_group_label>
    <arm_group_label>Aspirin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with transient ischemic attack (TIA) or ischemic stroke within 180 days prior
             to screening - Adult aged 20 years or older

          -  High risk of hemorrhagic stroke (history of intracranial hemorrhage or imaging
             evidence of previous intracranial hemorrhage)

          -  Informed consent

        Exclusion Criteria:

          -  Clinical diagnosis of myocardial infarction or coronary intervention within 4 weeks

          -  Bleeding tendency

          -  Pregnant or breast-feeding woman

          -  Hemorrhagic stroke within 6 months

          -  Patient who was taking antithrombotic medication other than aspirin and does not agree
             to change the previous medication

          -  Severe cardiovascular disease such as cardiomyopathy or congestive heart failure

          -  Life expectancy less than one year

          -  Contraindication to long term aspirin use

          -  Enrolled in other clinical trial within 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun U. Kwon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of Neurology, Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pamela Youde Nethersole Eastern Hospital</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Christian Hospital</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin, NT</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chungbuk National University Hospital</name>
      <address>
        <city>Cheongju</city>
        <state>Chungbuk</state>
        <zip>361-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Cheonan Hospital</name>
      <address>
        <city>Cheonan</city>
        <state>Chungcheongnam-do</state>
        <zip>330-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonju Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon-do</state>
        <zip>220-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kwandong University College of Medicine Myongji Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <state>Goyang</state>
        <zip>412-270</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <state>Gyengsangnam-do</state>
        <zip>660-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Ansan Hospital</name>
      <address>
        <city>Ansan</city>
        <state>Gyeonggi-do</state>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Bucheon Hospital</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <zip>420-020</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Health Insurance Corporation Ilsan Hoapital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>411-719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Ilsan Paik Hospital</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi-do</state>
        <zip>411-706</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Guri Hospital</name>
      <address>
        <city>Guri</city>
        <state>Gyeonggi-do</state>
        <zip>471-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bundang Medical Center, CHA University</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uijeongbu St. Mary's Hospital</name>
      <address>
        <city>Uijeongbu</city>
        <state>Gyeonggi-do</state>
        <zip>480-821</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung changwon Medical Center</name>
      <address>
        <city>Changwon</city>
        <state>Gyeongsangnam-do</state>
        <zip>630-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University Hospital</name>
      <address>
        <city>Iksan</city>
        <state>Jeonbuk</state>
        <zip>570-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju-si</city>
        <state>Jeonbuk</state>
        <zip>561-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Chuncheon</city>
        <state>Kangwon-do</state>
        <zip>200-947</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chang Won Fatima hospital</name>
      <address>
        <city>Changwon</city>
        <state>Kyeongsangnam-do</state>
        <zip>641-560</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dongguk University International Hospital</name>
      <address>
        <city>Goyang</city>
        <state>Kyoungki-do</state>
        <zip>410-773</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang</city>
        <state>Kyunggi</state>
        <zip>430-070</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Kyunggi</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Kyunggi</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Pusan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>614-735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>626-770</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Center</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daegu Fatima Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>701-600</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eulji University Hospital</name>
      <address>
        <city>Daejon</city>
        <zip>302-799</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dongsan Medical Center</name>
      <address>
        <city>Deagu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Hospital</name>
      <address>
        <city>Deagu</city>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Deagu</city>
        <zip>705-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deagu Catholic University Hospital</name>
      <address>
        <city>Deagu</city>
        <zip>705-718</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Deajeon</city>
        <zip>301-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deajeon St.Mary's Hospital, The Catholic University of Korea</name>
      <address>
        <city>Deajeon</city>
        <zip>303-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chosun University Hospital</name>
      <address>
        <city>GwangJu</city>
        <zip>501-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Hoapital</name>
      <address>
        <city>Incheon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Inchon</city>
        <zip>400-103</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wallace Memorial Baptist Hospital</name>
      <address>
        <city>Pusan</city>
        <zip>609-728</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>100-799</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-746</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyung Hee University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>130-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>133-792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangdong Sacred Heart Hospital, Hallym University</name>
      <address>
        <city>Seoul</city>
        <zip>134-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-740</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Sanggye Paik Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>139-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konkuk Univ. Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>150-713</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hangang Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>150-719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangnam Sacred Heart Hospital, Hallym University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>150-950</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Borame Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>158-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eulji Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>280-1</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manila Doctors Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Santo Tomas</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Medical City</name>
      <address>
        <city>Pasig</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>Korea, Republic of</country>
    <country>Philippines</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2009</study_first_submitted>
  <study_first_submitted_qc>November 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <last_update_submitted>December 23, 2015</last_update_submitted>
  <last_update_submitted_qc>December 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Sun U. Kwon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Intracranial Hemorrhage</keyword>
  <keyword>Cilostazol</keyword>
  <keyword>Probucol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Cilostazol</mesh_term>
    <mesh_term>Probucol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>December 28, 2016</submitted>
    <returned>February 21, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

